NCT06266182

Brief Summary

This trial aimed to test internet-based Acceptance and Commitment Therapy (ACT) intervention to induce a meaning-making process in cancer patients following hematopoietic cell transplantation (HCT). ACT includes identifying personal values and engaging in activities consistent with these values, developing acceptance, as well as focusing on the present moment or performing activities with greater awareness. In total, 192 patients following the first (autologous or allogeneic) HCT will be randomly assigned in equal numbers to either the ACT intervention or an education session. Participants in both conditions will take part in 14-day training (about 5-10 minutes a day). The outcomes will be measured at baseline, during the intervention, immediately, 1 month, and 3 months after the intervention. Moreover, 6-9 additional participants will be randomly assigned to pre-intervention measurement length (1-3 weeks) before completing ACT intervention, followed by 7-day observations at the 2nd and 3rd post-intervention measure. The researchers hypothesized that ACT intervention would foster a meaning-making process and thus reduce distress induced by the discrepancy between global and situational meaning as compared to education.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2024

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 20, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

March 6, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

1.7 years

First QC Date

January 25, 2024

Last Update Submit

May 13, 2024

Conditions

Keywords

cancer patientshematopoietic cell transplantationACT-based interventionweb-based interventionmeaning-makingsubjective well-beingpsychological flexibilityrandomized controlled trialsingle-case experimental design

Outcome Measures

Primary Outcomes (1)

  • Distress (Global Meaning Violation Scale; GMVS)

    The GMVS measures meaning-related distress. It is a 12-item questionnaire (from the original, the item "health" was removed due to the context of the study) that assesses belief (5 items) and goal violations (7 items) in response to stressors on a 5-point scale ranging from 1 (not at all) to 5 (very much). The overall score is calculated by summing the scores of all 12 items, with a possible range of 12-60. Higher scores indicate greater meaning-related distress (greater global meaning violation).

    Change from baseline to immediately, 1 month and 3 months after intervention

Secondary Outcomes (17)

  • Illness perception (Brief-Illness Perception Questionnaire; B-IPQ)

    Change from baseline to immediately, 1 month and 3 months after intervention

  • Global meaning (Meaning in Life Questionnaire; MLQ)

    Change from baseline to immediately, 1 month and 3 months after intervention

  • Psychological flexibility (Comprehensive Assessment of Acceptance and Commitment Therapy Processes-9; CompACT-9)

    Change from baseline to immediately, 1 month and 3 months after intervention

  • Coping self-efficacy (Coping Self-Efficacy Scale; CSE - selected items)

    Change from baseline to immediately, 1 month and 3 months after intervention

  • Deliberate meaning-making (Core Beliefs Inventory; CBI)

    Change from baseline to immediately, 1 month and 3 months after intervention

  • +12 more secondary outcomes

Study Arms (2)

ACT intervention

EXPERIMENTAL

Participants in the ACT intervention arm will learn new adaptive ways to cope with difficulties (including difficult thoughts or feelings).

Behavioral: Acceptance and Commitment Therapy

Education

OTHER

Participants in the Education arm will become familiar with post-HCT recommendations. This will be a minimally enhanced usual care.

Behavioral: Education

Interventions

ACT intervention will start on the second day after hospital discharge and will take 14 days (+ day 0 with organizational information). Each day, participants will receive a web-based intervention consisting of educational and practical tasks/activities. Participants will learn to recognize moments of choice (actions that lead towards values or away from them) and to use attention flexibly to free themselves from the power of thoughts, to open up and accept emotions, and to be able to determine what is important and take action in line with values. All of the tasks will be available in written form and audio. The ACT intervention is built from standard ACT exercises.

Also known as: ACT-based intervention, ACT
ACT intervention
EducationBEHAVIORAL

Education will start on the second day after hospital discharge and will take 14 days (+ day 0 with organizational information). Each day, participants will receive information about post-transplant prescriptions along with exercises to support the implementation. Participants will learn about nutrition, personal hygiene, preventing infections, coping with fatigue, resuming activity, rest and sleep, engaging in social interactions, and sexual health. The content is prepared based on available guides for HCT recipients.

Education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Qualification for the first autologous or allogeneic HCT due to hematologic malignancies or solid tumors
  • Age ≥ 18 years
  • Signed written informed consent
  • Ability to read and write in Polish
  • Daily access to the Internet by computer and/or mobile device

You may not qualify if:

  • Major psychiatric or cognitive disorder that would impede providing informed consent and study participation
  • Inability to cooperate and give informed consent
  • Hearing, seeing, or movement impairment that precludes participation
  • Current participation in any form of psychotherapy
  • No access to the Internet
  • No access to a computer and/or mobile device
  • Inability to use a computer and/or mobile device and the Internet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Department of Bone Marrow Transplantation and Oncohematology

Gliwice, 44-102, Poland

RECRUITING

Related Publications (1)

  • Kroemeke A, Dudek J, Kijowska M, Owen R, Sobczyk-Kruszelnicka M. The effect of an online acceptance and commitment intervention on the meaning-making process in cancer patients following hematopoietic cell transplantation: study protocol for a randomized controlled trial enhanced with single-case experimental design. Trials. 2024 Jun 18;25(1):392. doi: 10.1186/s13063-024-08235-1.

MeSH Terms

Interventions

Acceptance and Commitment TherapyEducational Status

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Aleksandra Kroemeke, PhD

    SWPS University (University of Social Sciences and Humanities)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aleksandra Kroemeke, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This trial is enhanced by a single-case experimental design (SCED), in which all study participants will receive the same intervention (i.e., intervention study model: single group). In SCED, there is no masking. The estimated total number of participants to be enrolled in SCED is 6-9.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Associate professor

Study Record Dates

First Submitted

January 25, 2024

First Posted

February 20, 2024

Study Start

March 6, 2024

Primary Completion

December 1, 2025

Study Completion

April 1, 2026

Last Updated

May 16, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

The full protocol, dataset, statistical codes, and outputs will be made available at the Open Science Framework (OSF). Anonymized participant-level datasets will be publicly available, however, without demographics and clinical data due to privacy or ethical restrictions (the possibility of identification of participants). The data will be stored for at least 5 years after the end of the project unless other regulations lengthen the need to store the data or it is not necessary due to other reasons (e.g. documentation of research results).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Beginning 3 months after publication without an end date.
Access Criteria
All those who will have an open link.
More information

Locations